BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.29
+0.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.29x
- Price / sales
- 1.49x
- Price / cash flow
- -80.83x
Enterprise value
- Enterprise value
- $105.3M
- EV / sales
- 1.38x
- EV / EBITDA
- -6.70x
- EV / EBIT
- -6.71x
- Market cap
- $114.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026